Can Neoadjuvant Chemotherapy before Definitive Surgery Improve Outcome in Operable Stage iVA Oral Cavity Cancers?

Autor: Cheung, KM, Ngan, RKC, Chow, JCH, Lee, TY, KWS Li, Cheng, HC, Leung, CWL, Yiu, HHY, Yau, S., Au, JSK, Wong, KH

Publikováno v: Hong Kong Journal of Radiology; 2018, Vol. 21 Issue 2, p124-131, 8p

Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification.

Autor: Pan JJ; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China.; Xiamen Humanity Hospital, Fujian Medical University Fujian, China.; American Joint Committee on Cancer Expert Panel., Mai HQ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Ng WT; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Hu CS; Fudan University Shanghai Cancer Center, Shanghai, China., Li JG; Jiangxi Cancer Hospital and NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang Medical College), Jiangxi, China., Chen XZ; Zhejiang Cancer Hospital, Zhejiang, China., Chow JCH; Queen Elizabeth Hospital, Hong Kong, China., Wong E; Pamela Youde Nethersole Eastern Hospital, Hong Kong, China., Lee V; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; The University of Hong Kong, China., Ma LY; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Guo QJ; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China., Liu Q; The University of Hong Kong, China., Liu LZ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Xu TT; Fudan University Shanghai Cancer Center, Shanghai, China., Gong XC; Jiangxi Cancer Hospital and NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang Medical College), Jiangxi, China., Qiang MY; Zhejiang Cancer Hospital, Zhejiang, China., Au KH; Queen Elizabeth Hospital, Hong Kong, China., Liu TC; Pamela Youde Nethersole Eastern Hospital, Hong Kong, China., Chiang CL; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; The University of Hong Kong, China., Xiao YP; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China., Lin SJ; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China., Chen YB; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China., Guo SS; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Wong CHL; The University of Hong Kong, China., Tang LQ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Xu ZY; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Jia YZ; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Peng WS; Fudan University Shanghai Cancer Center, Shanghai, China., Hu LP; Jiangxi Cancer Hospital and NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang Medical College), Jiangxi, China., Lu TZ; Jiangxi Cancer Hospital and NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang Medical College), Jiangxi, China., Jiang F; Zhejiang Cancer Hospital, Zhejiang, China., Cao CN; Zhejiang Cancer Hospital, Zhejiang, China., Xu W; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Ma J; American Joint Committee on Cancer Expert Panel.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Blanchard P; American Joint Committee on Cancer Expert Panel.; Union for International Cancer Control Head and Neck Core Group.; Department of Radiation Oncology, Université Paris-Saclay, INSERM U1018 Oncostat, Gustave-Roussy, Villejuif, France., Williams M; American Joint Committee on Cancer Expert Panel., Glastonbury CM; American Joint Committee on Cancer Expert Panel., King AD; American Joint Committee on Cancer Expert Panel.; The Chinese University of Hong Kong, China., Patel SG; American Joint Committee on Cancer Head and Neck Core Group.; Memorial Sloan Kettering Cancer Center, New York, New York., Seethala RR; American Joint Committee on Cancer Head and Neck Core Group.; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Colevas AD; American Joint Committee on Cancer Expert Panel.; Stanford University School of Medicine, Stanford, California., Fan DM; China Anti-Cancer Association., Chua MLK; American Joint Committee on Cancer Expert Panel.; Union for International Cancer Control Head and Neck Core Group.; National Cancer Centre Singapore and Duke-NUS Medical School, Singapore., Huang SH; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Union for International Cancer Control Head and Neck Core Group.; American Joint Committee on Cancer Head and Neck Core Group., O'Sullivan B; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Union for International Cancer Control Head and Neck Core Group.; American Joint Committee on Cancer Head and Neck Core Group., Lydiatt W; American Joint Committee on Cancer Head and Neck Core Group.; Nebraska Methodist Health System, Omaha, Nebraska., Lee AWM; American Joint Committee on Cancer Expert Panel.; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Union for International Cancer Control Head and Neck Core Group.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.

Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.

Autor: Chiang CL; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China. Electronic address: chiangcl@hku.hk., Chan KSK; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Li H; School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Ng WT; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Chow JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China., Choi HCW; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Lam KO; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Lee VHF; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Ngan RKC; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Lee AWM; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, and University of Hong Kong-Shenzhen Hospital, Hong Kong, China., Eschrich SA; Cvergenx, Inc St Petersburg, FL, United States., Torres-Roca JF; Cvergenx, Inc St Petersburg, FL, United States., Wong JWH; School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Electronic address: jwhwong@hku.hk.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110287. Date of Electronic Publication: 2024 Apr 16.

Stereotactic Body Radiotherapy as a Curative Treatment for De Novo Mucosal Carcinoma of the Head and Neck: A Feasible Alternative Option for Fragile Patients with Small Lesion: A Systematic Review.

Autor: Strojan P; Department of Radiation Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Kokalj M; Department of Radiation Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia., Plavc G; Department of Radiation Oncology, Institute of Oncology Ljubljana, 1000 Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia., Ng SP; Department of Radiation Oncology, Austin Health, The University of Melbourne, Melbourne, VIC 3000, Australia., Nuyts S; Laboratory of Experimental Radiotherapy, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, 3000 Leuven, Belgium., Chiesa-Estomba CM; Department of Otorhinolaryngology-Head & Neck Surgery, Hospital Universitario Donostia, 20014 San Sebastian, Spain.; Biodonostia Research Institute, Faculty of Medicine, Deusto University, 20014 San Sebastian, Spain., Eisbruch A; Department of Radiation Oncology, University of Michigan Medicine, Ann Arbor, MI 48109, USA., de Bree R; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Chow JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, Hong Kong, China., Mäkitie AA; Department of Otorhinolaryngology-Head and Neck Surgery, Research Program in Systems Oncology, University of Helsinki and Helsinki University Hospital, FI-00014 Helsinki, Finland., Lopez F; Department of Otorhinolaryngology-Head and Neck Surgery, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, University of Oviedo, 33011 Oviedo, Spain., Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA., Ferlito A; Coordinator of the International Head and Neck Scientific Group, 35125 Padua, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2024 May 31; Vol. 16 (11). Date of Electronic Publication: 2024 May 31.

Neurological complications of modern radiotherapy for head and neck cancer.

Autor: Chow JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region. Electronic address: cch932@ha.org.hk., Ho JCS; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region., Cheung KM; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region., Johnson D; Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong Special Administrative Region., Ip BYM; Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region., Beitler JJ; Harold Alfond Center for Cancer Care, Maine General Hospital, Augusta, ME, USA., Strojan P; Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia., Mäkitie AA; Department of Otorhinolaryngology, Head and Neck Surgery, Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Eisbruch A; Department of Radiation Oncology, University of Michigan Medicine, Ann Arbor, MI, USA., Ng SP; Department of Radiation Oncology, Olivia Newton-John Cancer Centre, Austin Health, Melbourne, Australia., Nuyts S; Department of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium; Laboratory of Experimental Radiotherapy, Department of Oncology, University of Leuven, Leuven, Belgium., Mendenhall WM; Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA., Babighian S; Department of Ophthalmology, Ospedale Sant'Antonio, Azienda Ospedaliera, Padova, Italy., Ferlito A; Coordinator of the International Head and Neck Scientific Group, Padua, Italy.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 May; Vol. 194, pp. 110200. Date of Electronic Publication: 2024 Mar 02.